Transamerica Financial Advisors, LLC
Position in AMRX — Amneal Pharmaceuticals, Inc.
CIK 1502149
CEDAR RAPIDS, IA
Position in AMRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$106,276
+$69,560 QoQ
Shares Held
8,550
+193.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Transamerica Financial Advisors, LLC holds $5,979,445 across 18 Drug Manufacturers - Specialty & Generic names. AMRX ranks #3 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
234,167 | $5,603,616 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
310 | $183,823 | |
| 3 | AMRX |
Amneal Pharmaceuticals, Inc.
This page
|
8,550 | $106,276 | |
| 4 | HLN |
Haleon plc
|
2,815 | $28,178 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
139 | $18,311 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
768 | $14,223 | |
| 7 | ZTS |
Zoetis Inc.
|
110 | $13,003 | |
| 8 | VTRS |
Viatris Inc
|
644 | $8,700 |
All Filings in AMRX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $106,276 | 8,550 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $36,716 | 2,914 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,544 | 454 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||